Frequency and spectrum of cancers in the Peutz-Jeghers syndrome - PubMed (original) (raw)
. 2006 May 15;12(10):3209-15.
doi: 10.1158/1078-0432.CCR-06-0083.
Valérie Schumacher, Fred H Menko, Sylviane Olschwang, Lisa A Boardman, Johan J P Gille, Josbert J Keller, Anne Marie Westerman, Rodney J Scott, Wendy Lim, Jill D Trimbath, Francis M Giardiello, Stephen B Gruber, G Johan A Offerhaus, Felix W M de Rooij, J H Paul Wilson, Anika Hansmann, Gabriela Möslein, Brigitte Royer-Pokora, Tilman Vogel, Robin K S Phillips, Allan D Spigelman, Richard S Houlston
Affiliations
- PMID: 16707622
- DOI: 10.1158/1078-0432.CCR-06-0083
Free article
Frequency and spectrum of cancers in the Peutz-Jeghers syndrome
Nicholas Hearle et al. Clin Cancer Res. 2006.
Free article
Abstract
Background: Although an increased cancer risk in Peutz-Jeghers syndrome is established, data on the spectrum of tumors associated with the disease and the influence of germ-line STK11/LKB1 (serine/threonine kinase) mutation status are limited.
Experimental design: We analyzed the incidence of cancer in 419 individuals with Peutz-Jeghers syndrome, and 297 had documented STK11/LKB1 mutations.
Results: Ninety-six cancers were found among individuals with Peutz-Jeghers syndrome. The risk for developing cancer at ages 20, 30, 40, 50, 60, and 70 years was 2%, 5%, 17%, 31%, 60%, and 85%, respectively. The most common cancers represented in this analysis were gastrointestinal in origin, gastroesophageal, small bowel, colorectal, and pancreatic, and the risk for these cancers at ages 30, 40, 50, and 60 years was 1%, 9%, 15%, and 33%, respectively. In women with Peutz-Jeghers syndrome, the risk of breast cancer was substantially increased, being 8% and 31% at ages 40 and 60 years, respectively. Kaplan-Meier analysis showed that cancer risks were similar in Peutz-Jeghers syndrome patients with identified STK11/LKB1 mutations and those with no detectable mutation (log-rank test of difference chi2 = 0.62; 1 df; P = 0.43). Furthermore, the type or site of STK11/LKB1 mutation did not significantly influence cancer risk.
Conclusions: The results from our study provide quantitative information on the spectrum of cancers and risks of specific cancer types associated with Peutz-Jeghers syndrome.
Similar articles
- Cancer risks in LKB1 germline mutation carriers.
Mehenni H, Resta N, Park JG, Miyaki M, Guanti G, Costanza MC. Mehenni H, et al. Gut. 2006 Jul;55(7):984-90. doi: 10.1136/gut.2005.082990. Epub 2006 Jan 11. Gut. 2006. PMID: 16407375 Free PMC article. - Cancer risk associated with STK11/LKB1 germline mutations in Peutz-Jeghers syndrome patients: results of an Italian multicenter study.
Resta N, Pierannunzio D, Lenato GM, Stella A, Capocaccia R, Bagnulo R, Lastella P, Susca FC, Bozzao C, Loconte DC, Sabbà C, Urso E, Sala P, Fornasarig M, Grammatico P, Piepoli A, Host C, Turchetti D, Viel A, Memo L, Giunti L, Stigliano V, Varesco L, Bertario L, Genuardi M, Lucci Cordisco E, Tibiletti MG, Di Gregorio C, Andriulli A, Ponz de Leon M; AIFEG. Resta N, et al. Dig Liver Dis. 2013 Jul;45(7):606-11. doi: 10.1016/j.dld.2012.12.018. Epub 2013 Feb 15. Dig Liver Dis. 2013. PMID: 23415580 - Low frequency of somatic mutations in the LKB1/Peutz-Jeghers syndrome gene in sporadic breast cancer.
Bignell GR, Barfoot R, Seal S, Collins N, Warren W, Stratton MR. Bignell GR, et al. Cancer Res. 1998 Apr 1;58(7):1384-6. Cancer Res. 1998. PMID: 9537235 - Genetic screening for Peutz-Jeghers syndrome.
Ballhausen WG, Günther K. Ballhausen WG, et al. Expert Rev Mol Diagn. 2003 Jul;3(4):471-9. doi: 10.1586/14737159.3.4.471. Expert Rev Mol Diagn. 2003. PMID: 12877386 Review. - Update on our investigation of malignant tumors associated with Peutz-Jeghers syndrome in Japan.
Ishida H, Tajima Y, Gonda T, Kumamoto K, Ishibashi K, Iwama T. Ishida H, et al. Surg Today. 2016 Nov;46(11):1231-42. doi: 10.1007/s00595-015-1296-y. Epub 2016 Jan 8. Surg Today. 2016. PMID: 26746637 Review.
Cited by
- A Case Report of a Young Adult With Peutz-Jeghers Syndrome Presenting With Acute Small Bowel Obstruction: A Common Complication of an Uncommon Disease.
Kuruvila A, Philip P, Thomas A, Benjamin G. Kuruvila A, et al. Cureus. 2024 Aug 1;16(8):e65931. doi: 10.7759/cureus.65931. eCollection 2024 Aug. Cureus. 2024. PMID: 39221343 Free PMC article. - Gastrointestinal Malignancy: Genetic Implications to Clinical Applications.
Trembath HE, Yeh JJ, Lopez NE. Trembath HE, et al. Cancer Treat Res. 2024;192:305-418. doi: 10.1007/978-3-031-61238-1_15. Cancer Treat Res. 2024. PMID: 39212927 Review. - Clinical and Molecular Analysis in Patients with Peutz-Jeghers Syndrome.
Aslan PG, Çağlayan AO, Bora E, Koç A, Yücel H, Ülgenalp A, Öztürk Y, Şeker G, Akarsu M. Aslan PG, et al. Turk J Gastroenterol. 2024 Mar 25;35(5):374-384. doi: 10.5152/tjg.2024.23262. Turk J Gastroenterol. 2024. PMID: 39115133 Free PMC article. - Genetic variation at a splicing branch point in intron 7 of STK11: a rare variant decreasing its expression in a Chinese family with Peutz-Jeghers syndrome.
Wang X, Li Y, Zhang J, Liu C, Deng A, Li J. Wang X, et al. World J Surg Oncol. 2024 Jul 30;22(1):202. doi: 10.1186/s12957-024-03475-6. World J Surg Oncol. 2024. PMID: 39080663 Free PMC article. - Evaluating predictors of kinase activity of STK11 variants identified in primary human non-small cell lung cancers.
Chen Y, Lee K, Woo J, Kim DW, Keum C, Babbi G, Casadio R, Martelli PL, Savojardo C, Manfredi M, Shen Y, Sun Y, Katsonis P, Lichtarge O, Pejaver V, Seward DJ, Kamandula A, Bakolitsa C, Brenner SE, Radivojac P, O'Donnell-Luria A, Mooney SD, Jain S. Chen Y, et al. Res Sq [Preprint]. 2024 Jul 2:rs.3.rs-4587317. doi: 10.21203/rs.3.rs-4587317/v1. Res Sq. 2024. PMID: 39011112 Free PMC article. Preprint.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous